{
  "id": "NGN_MC_BATCH-300-91-1771347515793",
  "itemType": "standalone",
  "questionType": "multipleChoice",
  "topic": "Myasthenia Gravis",
  "subTopic": "Crisis Management",
  "cognitiveLevel": "Analyze",
  "difficulty": 4,
  "scenario": {
    "title": "Emergency Department Visit for Worsening Weakness",
    "body": "A 45-year-old client with a 5-year history of myasthenia gravis (MG) is brought to the emergency department by a family member. The client is visibly distressed and states, \"I took my pyridostigmine about an hour ago, but my breathing feels harder, and my muscles feel even weaker. I'm also having bad stomach cramps.\" The nurse performs a rapid assessment.",
    "cues": [
      {
        "type": "text",
        "label": "Client Statement",
        "value": "Reports taking pyridostigmine 1 hour ago with subsequent worsening of muscle weakness and respiratory effort, along with new abdominal cramping."
      },
      {
        "type": "vitalSign",
        "label": "Heart Rate",
        "value": "52/min"
      },
      {
        "type": "vitalSign",
        "label": "Respiratory Rate",
        "value": "24/min, shallow"
      },
      {
        "type": "vitalSign",
        "label": "Blood Pressure",
        "value": "100/60 mmHg"
      },
      {
        "type": "vitalSign",
        "label": "SpO2",
        "value": "91% on room air"
      },
      {
        "type": "finding",
        "label": "Neurological Assessment",
        "value": "Pinpoint pupils (miosis), muscle fasciculations noted around the eyes and mouth."
      },
      {
        "type": "finding",
        "label": "General Appearance",
        "value": "Profuse salivation and diaphoresis."
      }
    ]
  },
  "question": "The nurse analyzes the client's assessment findings. Which condition should the nurse suspect is developing?",
  "options": [
    {
      "id": "opt_1",
      "text": "Myasthenic crisis"
    },
    {
      "id": "opt_2",
      "text": "Cholinergic crisis"
    },
    {
      "id": "opt_4",
      "text": "Guillain-Barré syndrome"
    },
    {
      "id": "opt_3",
      "text": "Aspiration pneumonia"
    }
  ],
  "correctAnswer": "opt_2",
  "answerBreakdown": {
    "cjjmStep": "Analyze Cues",
    "rationales": [
      {
        "optionId": "opt_1",
        "isCorrect": false,
        "explanation": "Incorrect. Myasthenic crisis occurs due to inadequate anticholinesterase medication, leading to acetylcholine deficiency at the neuromuscular junction. This results in severe muscle weakness, potentially causing respiratory failure. Symptoms include ptosis, diplopia, dysphagia, and generalized weakness. While respiratory distress is present, the *worsening* of symptoms *after* pyridostigmine administration is inconsistent with myasthenic crisis. ClinicalPearl: Edrophonium (Tensilon) test can help differentiate; improvement suggests myasthenic crisis.",
        "pathophysiology": "In myasthenic crisis, insufficient acetylcholine (ACh) at the neuromuscular junction prevents adequate muscle stimulation. This can be due to under-dosing of anticholinesterase medications or disease exacerbation. The lack of ACh leads to impaired muscle contraction and subsequent weakness."
      },
      {
        "optionId": "opt_2",
        "isCorrect": true,
        "explanation": "Correct. Cholinergic crisis is caused by excessive acetylcholine (ACh) at the neuromuscular junction due to overmedication with anticholinesterase inhibitors (e.g., pyridostigmine). This leads to overstimulation of muscarinic and nicotinic receptors. The client's bradycardia (HR 52), miosis (pinpoint pupils), increased salivation, diaphoresis, abdominal cramping, muscle fasciculations, and *worsening* weakness after pyridostigmine strongly suggest cholinergic crisis. ClinicalPearl: Remember the mnemonic SLUDGE (Salivation, Lacrimation, Urination, Defecation, GI upset, Emesis) to recall muscarinic effects.",
        "pathophysiology": "Excessive ACh at the neuromuscular junction causes continuous depolarization of the motor endplate. This leads to an initial period of muscle stimulation (fasciculations) followed by paralysis due to the motor endplate becoming unresponsive to further stimulation. Muscarinic receptor overstimulation causes bradycardia, increased secretions, and GI motility. Nicotinic receptor overstimulation causes muscle fasciculations and weakness."
      },
      {
        "optionId": "opt_3",
        "isCorrect": false,
        "explanation": "Incorrect. Aspiration pneumonia is a potential complication of MG due to bulbar muscle weakness and impaired swallowing, increasing the risk of aspiration. While the client's respiratory rate is elevated, other key signs of pneumonia (fever, productive cough, abnormal lung sounds) are absent. The acute worsening of weakness *after* medication and the cholinergic signs are not explained by pneumonia. ClinicalPearl: Clients with MG and dysphagia should be assessed for aspiration risk and placed on aspiration precautions.",
        "pathophysiology": "Aspiration pneumonia occurs when foreign material (e.g., food, saliva, gastric contents) enters the lungs, causing inflammation and infection. In MG, bulbar muscle weakness impairs the gag reflex and swallowing coordination, increasing the risk of aspiration. This leads to an inflammatory response in the lungs, potentially causing pneumonia."
      },
      {
        "optionId": "opt_4",
        "isCorrect": false,
        "explanation": "Incorrect. Guillain-Barré syndrome (GBS) is an autoimmune disorder causing acute inflammatory demyelination of peripheral nerves, leading to ascending paralysis. While GBS also causes muscle weakness, it typically presents with progressive, symmetrical weakness starting in the lower extremities and ascending upwards. The client's history of MG, the *worsening* of symptoms *after* pyridostigmine, and the cholinergic signs are inconsistent with GBS. ClinicalPearl: GBS often follows a respiratory or gastrointestinal infection.",
        "pathophysiology": "In GBS, the immune system mistakenly attacks the myelin sheath of peripheral nerves, causing demyelination and impaired nerve conduction. This leads to muscle weakness, sensory disturbances, and autonomic dysfunction. The weakness typically starts in the distal extremities and ascends proximally."
      }
    ]
  },
  "clientNeeds": [
    "Physiological Integrity",
    "Reduction of Risk Potential",
    "Pharmacological and Parenteral Therapies"
  ],
  "references": [
    {
      "source": "Ignatavicius, D. D., Workman, M. L., Rebar, C. R., & Heimgartner, N. M. (2021). Medical-surgical nursing: Concepts for interprofessional collaborative care (10th ed.). Elsevier.",
      "chapter": "Chapter 41: Care of Patients with Problems of the Central Nervous System: The Brain"
    },
    {
      "source": "Lewis, S. L., Bucher, L., Heitkemper, M. M., & Harding, M. M. (2020). Medical-surgical nursing: Assessment and management of clinical problems (11th ed.). Elsevier.",
      "chapter": "Chapter 59: Neurologic Problems"
    }
  ],
  "sbar": {
    "situation": "45-year-old female with Myasthenia Gravis presented to the ED with increased weakness and respiratory distress after taking pyridostigmine.",
    "background": "Patient has a 5-year history of MG, managed with pyridostigmine. She took her usual dose one hour prior to arrival.",
    "assessment": "HR 52, RR 24 and shallow, BP 100/60, SpO2 91% on room air. Pinpoint pupils, muscle fasciculations, profuse salivation and diaphoresis. Reports abdominal cramping and worsening weakness. Possible cholinergic crisis.",
    "recommendation": "Hold pyridostigmine. Prepare to administer atropine. Monitor respiratory status closely and be prepared to provide ventilatory support. Obtain ABGs. Consider edrophonium (Tensilon) test to differentiate between cholinergic and myasthenic crisis. Notify neurologist."
  },
  "sentinelStatus": "healed_v2026_v8"
}